In an article called, “Trump coaxes big promises from big pharma,” Jane is quoted on the recent announcements from pharma companies who are reducing certain prescription drug prices through the end of 2018. ‘This is not a policy, this is self-regulation – these are ad hoc agreements that are verbal and can change,’ Jane explained. Check out the in-depth analysis by Rebecca Trager.
Jane quoted in Royal Society of Chemistry journal on President Trump’s prescription drug pricing policy
By Jane Sarasohn-Kahn on 25 July 2018 in
I'm once again pretty gobsmackingly happy to have been named a judge for the 2026 CES Innovation Awards, focusing on digital health, longevity, and fitness. Preceding every year's global conference, CES receives hundreds of applications from innovators around the world building tech-based solutions to big challenges. So glad to be part of this annual initiative to see what global health-tech pioneers are cooking up to address and scale the health and well-being of fellow health citizens, globally.
You can see the results of the Digital Health Awardees here on the #CES2026 website.
Stay tuned to Health Populi in early January as I'll be attending Media Days and meeting with innovators in digital health, longevity, and the home-for-health during CES 2026 in Las Vegas. I'll be at the conference for an entire week meeting with clients and exhibitors at the biggest-meeting-of-the-year on consumer-facing technology. I'll be reporting daily from Vegas here in the blog, sharing with you insights about the latest breakthroughs, products, and services that enable people to manage health, well-being, and medical issues in their own hands and homes.
Jane collaborated on Robin Strongin's Health Dame webcast to discuss Halle Tecco's new book, Massively Better Healthcare, due out in early 2026. We brainstormed with Maven Founder Kate Ryder and the company's Chief Medical Officer Dr. Neel Shah about the state of U.S. healthcare and solutions not just to tweak at the margins but to "massively" improve health care delivery, financing, outcomes, and equity in America. It was a delightful, enlightening conversation -- I hope you'll check it out.